{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:47Z","timestamp":1792783367616,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Program Funded by Education Department of Shaanxi Provincial Government","award":["No.23JS049"],"award-info":[{"award-number":["No.23JS049"]}],"id":[{"id":"https:\/\/ror.org\/00jb7xy46","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"DOI":"10.1007\/s11910-026-01520-3","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:30:51Z","timestamp":1789716651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Nanomedicine for Brain Tumors: Overcoming Biological Barriers, Targeting Strategies, and Future Directions"],"prefix":"10.1007","volume":"26","author":[{"given":"Yajing","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengtao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-527X","authenticated-orcid":false,"given":"Xingchun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1520_CR1","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1186\/s12885-024-13320-4","volume":"24","author":"R Poursaeed","year":"2024","unstructured":"Poursaeed R, Mohammadzadeh M, Safaei AA. Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review. BMC Cancer. 2024;24:1581. https:\/\/doi.org\/10.1186\/s12885-024-13320-4.","journal-title":"BMC Cancer"},{"key":"1520_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.5137\/1019-5149.JTN.26398-19.3","volume":"30","author":"H Saginc","year":"2020","unstructured":"Saginc H, Baltalarli PB, Sagtas E, Coskun ME. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies. Turk Neurosurg. 2020;30:822\u201331. https:\/\/doi.org\/10.5137\/1019-5149.JTN.26398-19.3.","journal-title":"Turk Neurosurg"},{"key":"1520_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-020-03451-6","volume":"147","author":"L Marenco-Hillembrand","year":"2020","unstructured":"Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D, Hammack J, Ortiz K, Lesser E, et al. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis. J Neurooncol. 2020;147:297\u2013307. https:\/\/doi.org\/10.1007\/s11060-020-03451-6.","journal-title":"J Neurooncol"},{"key":"1520_CR4","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017;19:1511\u201321. https:\/\/doi.org\/10.1093\/neuonc\/nox077.","journal-title":"Neuro Oncol"},{"key":"1520_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12987-026-00760-2","volume":"23","author":"G Gampa","year":"2026","unstructured":"Gampa G, Vadlakonda R, Stefanich E, Kamath AV, Sadekar S, Shivva V. Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain. Fluids Barriers CNS. 2026;23:25. https:\/\/doi.org\/10.1186\/s12987-026-00760-2.","journal-title":"Fluids Barriers CNS"},{"key":"1520_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transduct Target Ther"},{"key":"1520_CR7","doi-asserted-by":"publisher","unstructured":"Mo F, Pellerino A, Soffietti R, Ruda R. Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222312654.","DOI":"10.3390\/ijms222312654"},{"key":"1520_CR8","doi-asserted-by":"publisher","unstructured":"Wu SK, Tsai CL, Huang Y, Hynynen K. Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor. Pharmaceutics. 2020;13. https:\/\/doi.org\/10.3390\/pharmaceutics13010015.","DOI":"10.3390\/pharmaceutics13010015"},{"key":"1520_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20:26\u201341. https:\/\/doi.org\/10.1038\/s41568-019-0205-x.","journal-title":"Nat Rev Cancer"},{"key":"1520_CR10","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/IJN.S146315","volume":"12","author":"FU Din","year":"2017","unstructured":"Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomed. 2017;12:7291\u2013309. https:\/\/doi.org\/10.2147\/IJN.S146315.","journal-title":"Int J Nanomed"},{"key":"1520_CR11","doi-asserted-by":"publisher","first-page":"109996","DOI":"10.1016\/j.cclet.2024.109996","volume":"36","author":"H Wu","year":"2025","unstructured":"Wu H, Wang Y, Ren Z, Cong H, Shen Y, Yu B. The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy. Chin Chem Lett. 2025;36:109996. https:\/\/doi.org\/10.1016\/j.cclet.2024.109996.","journal-title":"Chin Chem Lett"},{"key":"1520_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1021\/acs.bioconjchem.4c00300","volume":"35","author":"Y Song","year":"2024","unstructured":"Song Y, Huang Q, Pu Q, Ni S, Zhu W, Zhao W, Xu H, Hu K. Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide. Bioconjug Chem. 2024;35:1380\u201390. https:\/\/doi.org\/10.1021\/acs.bioconjchem.4c00300.","journal-title":"Bioconjug Chem"},{"key":"1520_CR13","doi-asserted-by":"publisher","unstructured":"Song Z, Huang X, Wang J, Cai F, Zhao P, Yan F. Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood-Brain Barrier Opening. Pharmaceutics. 2021;13. https:\/\/doi.org\/10.3390\/pharmaceutics13081270.","DOI":"10.3390\/pharmaceutics13081270"},{"key":"1520_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/10731190903356495","volume":"37","author":"B Kong","year":"2009","unstructured":"Kong B, Sun Y, Li Y, Hu D. Preparation and the influencing factors of timozolomide liposomes. Artif Cells Blood Substit Immobil Biotechnol. 2009;37:279\u201382. https:\/\/doi.org\/10.3109\/10731190903356495.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"1520_CR15","doi-asserted-by":"publisher","unstructured":"German-Cortes J, Vilar-Hernandez M, Rafael D, Abasolo I, Andrade F. Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment. Pharmaceutics. 2023;15. https:\/\/doi.org\/10.3390\/pharmaceutics15030831.","DOI":"10.3390\/pharmaceutics15030831"},{"key":"1520_CR16","doi-asserted-by":"publisher","first-page":"104709","DOI":"10.1016\/j.jddst.2023.104709","volume":"86","author":"M Akanda","year":"2023","unstructured":"Akanda M, Mithu MDSH, Douroumis D. Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment. J Drug Deliv Sci Technol. 2023;86:104709. https:\/\/doi.org\/10.1016\/j.jddst.2023.104709.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1520_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/encyclopedia2020063","volume":"2","author":"T-T-L Nguyen","year":"2022","unstructured":"Nguyen T-T-L, Duong V-A. Solid Lipid Nanoparticles. Encyclopedia. 2022;2:952\u201373. https:\/\/doi.org\/10.3390\/encyclopedia2020063.","journal-title":"Encyclopedia"},{"key":"1520_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2018.12.009","volume":"295","author":"A Papachristodoulou","year":"2019","unstructured":"Papachristodoulou A, Signorell RD, Werner B, Brambilla D, Luciani P, Cavusoglu M, Grandjean J, Silginer M, Rudin M, Martin E, et al. Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes. J Control Release. 2019;295:130\u20139. https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.009.","journal-title":"J Control Release"},{"key":"1520_CR19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","volume":"19","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Qin J, Yu D, Liu Y, Song D, Tian K, Chen H, Ye Q, Wang X, Xu T, et al. Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol. 2024;19:1869\u201379. https:\/\/doi.org\/10.1038\/s41565-024-01769-0.","journal-title":"Nat Nanotechnol"},{"key":"1520_CR20","doi-asserted-by":"publisher","unstructured":"Jnaidi R, Almeida AJ, Goncalves LM. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme. Pharmaceutics. 2020;12. https:\/\/doi.org\/10.3390\/pharmaceutics12090860.","DOI":"10.3390\/pharmaceutics12090860"},{"key":"1520_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","volume":"264","author":"C Tapeinos","year":"2017","unstructured":"Tapeinos C, Battaglini M, Ciofani G. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Control Release. 2017;264:306\u201332. https:\/\/doi.org\/10.1016\/j.jconrel.2017.08.033.","journal-title":"J Control Release"},{"key":"1520_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejpb.2018.09.012","volume":"132","author":"A Kadari","year":"2018","unstructured":"Kadari A, Pooja D, Gora RH, Gudem S, Kolapalli VRM, Kulhari H, Sistla R. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. Eur J Pharm Biopharm. 2018;132:168\u201379. https:\/\/doi.org\/10.1016\/j.ejpb.2018.09.012.","journal-title":"Eur J Pharm Biopharm"},{"key":"1520_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/btpr.2214","volume":"32","author":"YC Kuo","year":"2016","unstructured":"Kuo YC, Chao IW. Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy. Biotechnol Prog. 2016;32:480\u201390. https:\/\/doi.org\/10.1002\/btpr.2214.","journal-title":"Biotechnol Prog"},{"key":"1520_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nano.2012.03.003","volume":"9","author":"VK Venishetty","year":"2013","unstructured":"Venishetty VK, Komuravelli R, Kuncha M, Sistla R, Diwan PV. Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine. 2013;9:111\u201321. https:\/\/doi.org\/10.1016\/j.nano.2012.03.003.","journal-title":"Nanomedicine"},{"key":"1520_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/1061186X.2015.1068320","volume":"24","author":"I Singh","year":"2016","unstructured":"Singh I, Swami R, Pooja D, Jeengar MK, Khan W, Sistla R. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. J Drug Target. 2016;24:212\u201323. https:\/\/doi.org\/10.3109\/1061186X.2015.1068320.","journal-title":"J Drug Target"},{"key":"1520_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/17435889.2024.2434452","volume":"20","author":"L Battaglia","year":"2025","unstructured":"Battaglia L, Dianzani C, Muntoni E, Marini E, Bozza A, Bordano V, Ferraris C, Garelli S, Valsania MC, Terreno E, et al. Ultrasmall solid lipid nanoparticles as a potential innovative delivery system for a drug combination against glioma. Nanomed (Lond). 2025;20:37\u201352. https:\/\/doi.org\/10.1080\/17435889.2024.2434452.","journal-title":"Nanomed (Lond)"},{"key":"1520_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","volume":"12","author":"A Beloqui","year":"2016","unstructured":"Beloqui A, Solinis MA, Rodriguez-Gascon A, Almeida AJ, Preat V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine. 2016;12:143\u201361. https:\/\/doi.org\/10.1016\/j.nano.2015.09.004.","journal-title":"Nanomedicine"},{"key":"1520_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43094-022-00414-8","volume":"8","author":"J Garg","year":"2022","unstructured":"Garg J, Pathania K, Sah SP, Pawar SV. Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future J Pharm Sci. 2022;8:25. https:\/\/doi.org\/10.1186\/s43094-022-00414-8.","journal-title":"Future J Pharm Sci"},{"key":"1520_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Adv Pharm Bull. 2023;13:446\u201360. https:\/\/doi.org\/10.34172\/apb.2023.056.","journal-title":"Adv Pharm Bull"},{"key":"1520_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","volume":"345","author":"M Farshbaf","year":"2022","unstructured":"Farshbaf M, Mojarad-Jabali S, Hemmati S, Khosroushahi AY, Motasadizadeh H, Zarebkohan A, Valizadeh H. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers. J Control Release. 2022;345:371\u201384. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.019.","journal-title":"J Control Release"},{"key":"1520_CR31","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1007\/s13346-024-01775-8","volume":"15","author":"M Horta","year":"2025","unstructured":"Horta M, Soares P, Sarmento B, Leite Pereira C, Lima RT. Nanostructured lipid carriers for enhanced batimastat delivery across the blood-brain barrier: an in vitro study for glioblastoma treatment. Drug Deliv Transl Res. 2025;15:2794\u2013813. https:\/\/doi.org\/10.1007\/s13346-024-01775-8.","journal-title":"Drug Deliv Transl Res"},{"key":"1520_CR32","doi-asserted-by":"publisher","unstructured":"Zielinska A, Carreiro F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, et al. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules. 2020;25. https:\/\/doi.org\/10.3390\/molecules25163731.","DOI":"10.3390\/molecules25163731"},{"key":"1520_CR33","doi-asserted-by":"publisher","first-page":"e2203894","DOI":"10.1002\/advs.202203894","volume":"9","author":"H Wu","year":"2022","unstructured":"Wu H, Gao X, Luo Y, Yu J, Long G, Jiang Z, Zhou J. Targeted Delivery of Chemo-Sonodynamic Therapy via Brain Targeting, Glutathione-Consumable Polymeric Nanoparticles for Effective Brain Cancer Treatment. Adv Sci (Weinh). 2022;9:e2203894. https:\/\/doi.org\/10.1002\/advs.202203894.","journal-title":"Adv Sci (Weinh)"},{"key":"1520_CR34","doi-asserted-by":"publisher","unstructured":"Whitney M, Crisp JL, Olson ES, Aguilera TA, Gross LA, Ellies LG, Tsien RY: Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides. J Biol Chem 2010; 285:22532-22541. https:\/\/doi.org\/10.1074\/jbc.M110.138297","DOI":"10.1074\/jbc.M110.138297"},{"key":"1520_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s11095-021-03050-8","volume":"38","author":"SB Smiley","year":"2021","unstructured":"Smiley SB, Yun Y, Ayyagari P, Shannon HE, Pollok KE, Vannier MW, Das SK, Veronesi MC. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells. Pharm Res. 2021;38:1067\u201379. https:\/\/doi.org\/10.1007\/s11095-021-03050-8.","journal-title":"Pharm Res"},{"key":"1520_CR36","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1007\/s12274-018-2152-3","volume":"11","author":"Y Lu","year":"2018","unstructured":"Lu Y, Zhang E, Yang J, Cao Z. Strategies to improve micelle stability for drug delivery. Nano Res. 2018;11:4985\u201398. https:\/\/doi.org\/10.1007\/s12274-018-2152-3.","journal-title":"Nano Res"},{"key":"1520_CR37","doi-asserted-by":"publisher","unstructured":"Vert M, Doi Y, Hellwich K-H, Hess M, Hodge P, Kubisa P, Rinaudo M, Schu\u00e9 F. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). 2012; 84:377\u2013410. https:\/\/doi.org\/10.1351\/PAC-REC-10-12-04","DOI":"10.1351\/PAC-REC-10-12-04"},{"key":"1520_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42269-025-01309-3","volume":"49","author":"AK Parashar","year":"2025","unstructured":"Parashar AK, Saraogi GK, Shrivastava V, Bagri R, Tyagi LK, Sethi VA, Jain PK. Development of Angiopep-2 targeted dendrimer-based nanotheranostic system for enhanced temozolomide delivery to glioblastoma multiforme. Bull Natl Res Centre. 2025;49:16. https:\/\/doi.org\/10.1186\/s42269-025-01309-3.","journal-title":"Bull Natl Res Centre"},{"key":"1520_CR39","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.biomaterials.2012.02.004","volume":"33","author":"Y Li","year":"2012","unstructured":"Li Y, He H, Jia X, Lu WL, Lou J, Wei Y. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials. 2012;33:3899\u2013908. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.02.004.","journal-title":"Biomaterials"},{"key":"1520_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/10717544.2013.876460","volume":"22","author":"VP Baklaushev","year":"2015","unstructured":"Baklaushev VP, Nukolova NN, Khalansky AS, Gurina OI, Yusubalieva GM, Grinenko NP, Gubskiy IL, Melnikov PA, Kardashova K, Kabanov AV, Chekhonin VP. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1. Drug Deliv. 2015;22:276\u201385. https:\/\/doi.org\/10.3109\/10717544.2013.876460.","journal-title":"Drug Deliv"},{"key":"1520_CR41","doi-asserted-by":"publisher","unstructured":"Caraway CA, Gaitsch H, Wicks EE, Kalluri A, Kunadi N, Tyler BM. Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches. Polym (Basel). 2022;14. https:\/\/doi.org\/10.3390\/polym14142963.","DOI":"10.3390\/polym14142963"},{"key":"1520_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jconrel.2022.07.023","volume":"349","author":"F Madani","year":"2022","unstructured":"Madani F, Esnaashari SS, Webster TJ, Khosravani M, Adabi M. Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives. J Control Release. 2022;349:649\u201361. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.023.","journal-title":"J Control Release"},{"key":"1520_CR43","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1016\/j.addr.2022.114415","volume":"9","author":"RK Sahoo","year":"2023","unstructured":"Pandey N, Anastasiadis P, Carney CP, Kanvinde PP, Woodworth GF, Winkles JA, Kim AJ. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment. Adv Drug Deliv Rev. 2022;188:114415. https:\/\/doi.org\/10.1016\/j.addr.2022.114415","journal-title":"ACS Biomater Sci Eng"},{"key":"1520_CR44","doi-asserted-by":"publisher","first-page":"372","DOI":"10.20892\/j.issn.2095-3941.2020.0524","volume":"18","author":"L Tu","year":"2021","unstructured":"Tu L, Luo Z, Wu YL, Huo S, Liang XJ. Gold-based nanomaterials for the treatment of brain cancer. Cancer Biol Med. 2021;18:372\u201387. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0524.","journal-title":"Cancer Biol Med"},{"key":"1520_CR45","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1002\/smll.201400654","volume":"10","author":"Y Cheng","year":"2014","unstructured":"Cheng Y, Dai Q, Morshed RA, Fan X, Wegscheid ML, Wainwright DA, Han Y, Zhang L, Auffinger B, Tobias AL, et al. Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging. Small. 2014;10:5137\u201350. https:\/\/doi.org\/10.1002\/smll.201400654.","journal-title":"Small"},{"key":"1520_CR46","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.7150\/thno.18985","volume":"7","author":"Q Feng","year":"2017","unstructured":"Feng Q, Shen Y, Fu Y, Muroski ME, Zhang P, Wang Q, Xu C, Lesniak MS, Li G, Cheng Y. Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting. Theranostics. 2017;7:1875\u201389. https:\/\/doi.org\/10.7150\/thno.18985.","journal-title":"Theranostics"},{"key":"1520_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-018-03005-x","volume":"141","author":"O Grauer","year":"2019","unstructured":"Grauer O, Jaber M, Hess K, Weckesser M, Schwindt W, Maring S, Wolfer J, Stummer W. Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients. J Neurooncol. 2019;141:83\u201394. https:\/\/doi.org\/10.1007\/s11060-018-03005-x.","journal-title":"J Neurooncol"},{"key":"1520_CR48","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biomaterials.2010.09.024","volume":"32","author":"H Xie","year":"2011","unstructured":"Xie H, Zhu Y, Jiang W, Zhou Q, Yang H, Gu N, Zhang Y, Xu H, Xu H, Yang X. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials. 2011;32:495\u2013502. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.09.024.","journal-title":"Biomaterials"},{"key":"1520_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","volume":"103","author":"K Maier-Hauff","year":"2011","unstructured":"Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103:317\u201324. https:\/\/doi.org\/10.1007\/s11060-010-0389-0.","journal-title":"J Neurooncol"},{"key":"1520_CR50","doi-asserted-by":"publisher","unstructured":"Cecilia JA, Moreno Tost R, Retuerto Millan M. Mesoporous Materials: From Synthesis to Applications. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20133213.","DOI":"10.3390\/ijms20133213"},{"key":"1520_CR51","doi-asserted-by":"publisher","unstructured":"Salazar A, Perez-de la Cruz V, Munoz-Sandoval E, Chavarria V, Garcia Morales ML, Espinosa-Bonilla A, Sotelo J, Jimenez-Anguiano A, Pineda B. Potential Use of Nitrogen-Doped Carbon Nanotube Sponges as Payload Carriers Against Malignant Glioma. Nanomaterials (Basel). 2021;11. https:\/\/doi.org\/10.3390\/nano11051244.","DOI":"10.3390\/nano11051244"},{"key":"1520_CR52","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S, Tong R, Miao YB, Cai L. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023;8:418. https:\/\/doi.org\/10.1038\/s41392-023-01642-x.","journal-title":"Signal Transduct Target Ther"},{"key":"1520_CR53","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.2147\/IJN.S139004","volume":"12","author":"S Romano-Feinholz","year":"2017","unstructured":"Romano-Feinholz S, Salazar-Ramiro A, Munoz-Sandoval E, Magana-Maldonado R, Hernandez Pedro N, Rangel Lopez E, Gonzalez Aguilar A, Sanchez Garcia A, Sotelo J, de la Perez V, Pineda B. Cytotoxicity induced by carbon nanotubes in experimental malignant glioma. Int J Nanomed. 2017;12:6005\u201326. https:\/\/doi.org\/10.2147\/IJN.S139004.","journal-title":"Int J Nanomed"},{"key":"1520_CR54","doi-asserted-by":"publisher","unstructured":"Zhou J, Liu C, Zhong Y, Luo Z, Wu L. A Review of Current Developments in Functionalized Mesoporous Silica Nanoparticles: From Synthesis to Biosensing Applications. Biosens (Basel). 2024;14. https:\/\/doi.org\/10.3390\/bios14120575.","DOI":"10.3390\/bios14120575"},{"key":"1520_CR55","doi-asserted-by":"crossref","unstructured":"Pednekar PP, Godiyal SC, Jadhav KR, Kadam VJ. Chap. 23 - Mesoporous silica nanoparticles: a promising multifunctional drug delivery system. In Nanostructures for Cancer Therapy. Edited by Ficai A, Grumezescu AM: Elsevier. 2017:593\u2013621.","DOI":"10.1016\/B978-0-323-46144-3.00023-4"},{"key":"1520_CR56","doi-asserted-by":"publisher","unstructured":"Turan O, Bielecki PA, Perera V, Lorkowski M, Covarrubias G, Tong K, Yun A, Loutrianakis G, Raghunathan S, Park Y, et al. Treatment of glioblastoma using multicomponent silica nanoparticles. Adv Ther (Weinh). 2019;2. https:\/\/doi.org\/10.1002\/adtp.201900118.","DOI":"10.1002\/adtp.201900118"},{"key":"1520_CR57","doi-asserted-by":"publisher","first-page":"e18490","DOI":"10.1016\/j.heliyon.2023.e18490","volume":"9","author":"P Zhang","year":"2023","unstructured":"Zhang P, Cao F, Zhang J, Tan Y, Yao S. Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma. Heliyon. 2023;9:e18490. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18490.","journal-title":"Heliyon"},{"key":"1520_CR58","doi-asserted-by":"publisher","unstructured":"Feng D, Zhang G, Li Y. Semiconductor Quantum Dots: Synthesis, Properties and Applications. Nanomaterials (Basel). 2024;14. https:\/\/doi.org\/10.3390\/nano14221825.","DOI":"10.3390\/nano14221825"},{"key":"1520_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.7497\/j.issn.2095-3941.2012.03.001","volume":"9","author":"M Fang","year":"2012","unstructured":"Fang M, Peng CW, Pang DW, Li Y. Quantum dots for cancer research: current status, remaining issues, and future perspectives. Cancer Biol Med. 2012;9:151\u201363. https:\/\/doi.org\/10.7497\/j.issn.2095-3941.2012.03.001.","journal-title":"Cancer Biol Med"},{"key":"1520_CR60","doi-asserted-by":"crossref","unstructured":"Tang X, Yang F. Quantum Dots: Synthesis, Characterization, and Applications. In Handbook of Energy Materials. Edited by Gupta R. Singapore: Springer Nature Singapore. 2022:1\u201330.","DOI":"10.1007\/978-981-16-4480-1_27-1"},{"key":"1520_CR61","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41551-020-0540-y","volume":"4","author":"S Li","year":"2020","unstructured":"Li S, Su W, Wu H, Yuan T, Yuan C, Liu J, Deng G, Gao X, Chen Z, Bao Y, et al. Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids. Nat Biomed Eng. 2020;4:704\u201316. https:\/\/doi.org\/10.1038\/s41551-020-0540-y.","journal-title":"Nat Biomed Eng"},{"key":"1520_CR62","doi-asserted-by":"publisher","unstructured":"Ag Seleci D, Maurer V, Barlas FB, Porsiel JC, Temel B, Ceylan E, Timur S, Stahl F, Scheper T, Garnweitner G. Transferrin-Decorated Niosomes with Integrated InP\/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22094556.","DOI":"10.3390\/ijms22094556"},{"key":"1520_CR63","doi-asserted-by":"publisher","first-page":"10179","DOI":"10.2147\/IJN.S220087","volume":"14","author":"H Yan","year":"2019","unstructured":"Yan H, Xue Z, Xie J, Dong Y, Ma Z, Sun X, Kebebe Borga D, Liu Z, Li J. Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers. Int J Nanomed. 2019;14:10179\u201394. https:\/\/doi.org\/10.2147\/IJN.S220087.","journal-title":"Int J Nanomed"},{"key":"1520_CR64","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.apsb.2019.09.009","volume":"10","author":"K Zhi","year":"2020","unstructured":"Zhi K, Wang J, Zhao H, Yang X. Self-assembled small molecule natural product gel for drug delivery: a breakthrough in new application of small molecule natural products. Acta Pharm Sin B. 2020;10:913\u201327. https:\/\/doi.org\/10.1016\/j.apsb.2019.09.009.","journal-title":"Acta Pharm Sin B"},{"key":"1520_CR65","doi-asserted-by":"publisher","first-page":"113868","DOI":"10.1016\/j.addr.2021.113868","volume":"176","author":"Y Xie","year":"2021","unstructured":"Xie Y, Ma C, Yang X, Wang J, Long G, Zhou J. Phytonanomaterials as therapeutic agents and drug delivery carriers. Adv Drug Deliv Rev. 2021;176:113868. https:\/\/doi.org\/10.1016\/j.addr.2021.113868.","journal-title":"Adv Drug Deliv Rev"},{"key":"1520_CR66","doi-asserted-by":"publisher","first-page":"e14528","DOI":"10.1111\/cns.14528","volume":"30","author":"Y Li","year":"2024","unstructured":"Li Y, Zhao Q, Zhu X, Zhou L, Song P, Liu B, Tian D, Chen Q, Zhou J, Deng G. Self-Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma. CNS Neurosci Ther. 2024;30:e14528. https:\/\/doi.org\/10.1111\/cns.14528.","journal-title":"CNS Neurosci Ther"},{"key":"1520_CR67","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1021\/acs.molpharmaceut.0c00044","volume":"17","author":"Y Bao","year":"2020","unstructured":"Bao Y, Zhang S, Chen Z, Chen AT, Ma J, Deng G, Xu W, Zhou J, Yu ZQ, Yao G, Chen J. Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles. Mol Pharm. 2020;17:1343\u201351. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00044.","journal-title":"Mol Pharm"},{"key":"1520_CR68","doi-asserted-by":"publisher","first-page":"2400081","DOI":"10.1002\/smsc.202400081","volume":"4","author":"Z Ye","year":"2024","unstructured":"Ye Z, Sheu WC, Qu H, Peng B, Liu J, Zhang L, Yuan F, Wei Y, Zhou J, Chen Q, et al. Autocatalytic, Brain Tumor-Targeting Delivery of Bardoxolone Methyl Self-Assembled Nanoparticles for Glioblastoma Treatment. Small Sci. 2024;4:2400081. https:\/\/doi.org\/10.1002\/smsc.202400081.","journal-title":"Small Sci"},{"key":"1520_CR69","doi-asserted-by":"publisher","first-page":"123035","DOI":"10.1016\/j.biomaterials.2024.123035","volume":"317","author":"X Gao","year":"2025","unstructured":"Gao X, Tang X, Tu Z, Yu J, Bao Y, Long G, Sheu WC, Wu H, Liu J, Zhou J. Tertiary amine modification enables triterpene nanoparticles to target the mitochondria and treat glioblastoma via pyroptosis induction. Biomaterials. 2025;317:123035. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123035.","journal-title":"Biomaterials"},{"key":"1520_CR70","doi-asserted-by":"publisher","unstructured":"Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-Based Nanoparticles as Drug Delivery Systems. Pharmaceutics. 2020;12. https:\/\/doi.org\/10.3390\/pharmaceutics12070604.","DOI":"10.3390\/pharmaceutics12070604"},{"key":"1520_CR71","doi-asserted-by":"publisher","first-page":"9285854","DOI":"10.1155\/2018\/9285854","volume":"2018","author":"D Verma","year":"2018","unstructured":"Verma D, Gulati N, Kaul S, Mukherjee S, Nagaich U. Protein Based Nanostructures for Drug Delivery. J Pharm (Cairo). 2018;2018:9285854. https:\/\/doi.org\/10.1155\/2018\/9285854.","journal-title":"J Pharm (Cairo)"},{"key":"1520_CR72","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","volume":"11","author":"JV Gregory","year":"2020","unstructured":"Gregory JV, Kadiyala P, Doherty R, Cadena M, Habeel S, Ruoslahti E, Lowenstein PR, Castro MG, Lahann J. Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy. Nat Commun. 2020;11:5687. https:\/\/doi.org\/10.1038\/s41467-020-19225-7.","journal-title":"Nat Commun"},{"key":"1520_CR73","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bioactmat.2022.02.026","volume":"16","author":"B Wang","year":"2022","unstructured":"Wang B, Tang M, Yuan Z, Li Z, Hu B, Bai X, Chu J, Xu X, Zhang XQ. Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy. Bioact Mater. 2022;16:232\u201348. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.026.","journal-title":"Bioact Mater"},{"key":"1520_CR74","doi-asserted-by":"publisher","unstructured":"Tikhonov A, Kachanov A, Yudaeva A, Danilik O, Ponomareva N, Karandashov I, Kostyusheva A, Zamyatnin AA Jr., Parodi A, Chulanov V, et al. Biomimetic Nanoparticles for Basic Drug Delivery. Pharmaceutics. 2024;16. https:\/\/doi.org\/10.3390\/pharmaceutics16101306.","DOI":"10.3390\/pharmaceutics16101306"},{"key":"1520_CR75","doi-asserted-by":"publisher","unstructured":"Beh CY, Prajnamitra RP, Chen LL, Hsieh PC. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis. Molecules. 2021;26. https:\/\/doi.org\/10.3390\/molecules26165052.","DOI":"10.3390\/molecules26165052"},{"key":"1520_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","volume":"23","author":"M Li","year":"2025","unstructured":"Li M, Lu L, Bao Q, Zhou M, Nie B, Liu Y, Shu K, Lei T, Zhu M. Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon. J Nanobiotechnol. 2025;23:239. https:\/\/doi.org\/10.1186\/s12951-025-03301-5.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR77","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41467-022-31799-y","volume":"13","author":"G Lu","year":"2022","unstructured":"Lu G, Wang X, Li F, Wang S, Zhao J, Wang J, Liu J, Lyu C, Ye P, Tan H, et al. Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma. Nat Commun. 2022;13:4214. https:\/\/doi.org\/10.1038\/s41467-022-31799-y.","journal-title":"Nat Commun"},{"key":"1520_CR78","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","volume":"10","author":"A Galstyan","year":"2019","unstructured":"Galstyan A, Markman JL, Shatalova ES, Chiechi A, Korman AJ, Patil R, Klymyshyn D, Tourtellotte WG, Israel LL, Braubach O, et al. Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nat Commun. 2019;10:3850. https:\/\/doi.org\/10.1038\/s41467-019-11719-3.","journal-title":"Nat Commun"},{"key":"1520_CR79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1021\/bc0502457","volume":"17","author":"BS Lee","year":"2006","unstructured":"Lee BS, Fujita M, Khazenzon NM, Wawrowsky KA, Wachsmann-Hogiu S, Farkas DL, Black KL, Ljubimova JY, Holler E. Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery. Bioconjug Chem. 2006;17:317\u201326. https:\/\/doi.org\/10.1021\/bc0502457.","journal-title":"Bioconjug Chem"},{"key":"1520_CR80","doi-asserted-by":"publisher","first-page":"101022","DOI":"10.1016\/j.ajps.2025.101022","volume":"20","author":"P Singh","year":"2025","unstructured":"Singh P, Sahel DK, Jatyan R, Bajaj K, Mittal A, Chitkara D. Enhancing temozolomide in vivo stability and efficacy through hybrid nanoconjugate approach for improved glioblastoma multiforme treatment. Asian J Pharm Sci. 2025;20:101022. https:\/\/doi.org\/10.1016\/j.ajps.2025.101022.","journal-title":"Asian J Pharm Sci"},{"key":"1520_CR81","doi-asserted-by":"publisher","unstructured":"Ramalho MJ, Loureiro JA, Coelho MAN, Pereira MC. Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14020279.","DOI":"10.3390\/pharmaceutics14020279"},{"key":"1520_CR82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","volume":"277","author":"A Jhaveri","year":"2018","unstructured":"Jhaveri A, Deshpande P, Pattni B, Torchilin V. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release. 2018;277:89\u2013101. https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.006.","journal-title":"J Control Release"},{"key":"1520_CR83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5650\/jos.ess24085","volume":"74","author":"LA Kumar","year":"2025","unstructured":"Kumar LA, Pattnaik G, Satapathy BS, Mohanty DL, Zafar A, Warsi MH, Khalid M, Mujtaba MA. Transferrin-modified Gemcitabine Encapsulated Polymeric Nanoparticles Persuaded Apoptosis in U87MG Cells and Improved Drug Availability in Rat Brain: An Active Targeting Strategy for Treatment of Glioma. J Oleo Sci. 2025;74:261\u201374. https:\/\/doi.org\/10.5650\/jos.ess24085.","journal-title":"J Oleo Sci"},{"key":"1520_CR84","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.2147\/IJN.S257459","volume":"15","author":"P Sun","year":"2020","unstructured":"Sun P, Xiao Y, Di Q, Ma W, Ma X, Wang Q, Chen W. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme. Int J Nanomed. 2020;15:6673\u201388. https:\/\/doi.org\/10.2147\/IJN.S257459.","journal-title":"Int J Nanomed"},{"key":"1520_CR85","doi-asserted-by":"publisher","first-page":"1204149","DOI":"10.3389\/fnagi.2023.1204149","volume":"15","author":"F Eker","year":"2023","unstructured":"Eker F, Bolat E, Pekdemir B, Duman H, Karav S. Lactoferrin: neuroprotection against Parkinson\u2019s disease and secondary molecule for potential treatment. Front Aging Neurosci. 2023;15:1204149. https:\/\/doi.org\/10.3389\/fnagi.2023.1204149.","journal-title":"Front Aging Neurosci"},{"key":"1520_CR86","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1039\/d2bm02152h","volume":"11","author":"J Li","year":"2023","unstructured":"Li J, Zhang Z, Zhang B, Yan X, Fan K. Transferrin receptor 1 targeted nanomedicine for brain tumor therapy. Biomater Sci. 2023;11:3394\u2013413. https:\/\/doi.org\/10.1039\/d2bm02152h.","journal-title":"Biomater Sci"},{"key":"1520_CR87","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.drudis.2021.02.008","volume":"26","author":"S Pawar","year":"2021","unstructured":"Pawar S, Koneru T, McCord E, Tatiparti K, Sau S, Iyer AK. LDL receptors and their role in targeted therapy for glioma: a review. Drug Discov Today. 2021;26:1212\u201325. https:\/\/doi.org\/10.1016\/j.drudis.2021.02.008.","journal-title":"Drug Discov Today"},{"key":"1520_CR88","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/1878-0261.13730","volume":"18","author":"E Mastrantuono","year":"2024","unstructured":"Mastrantuono E, Ghibaudi M, Matias D, Battaglia G. The multifaceted therapeutical role of low-density lipoprotein receptor family in high-grade glioma. Mol Oncol. 2024;18:2966\u201376. https:\/\/doi.org\/10.1002\/1878-0261.13730.","journal-title":"Mol Oncol"},{"key":"1520_CR89","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijbiomac.2017.08.155","volume":"107","author":"H Li","year":"2018","unstructured":"Li H, Tong Y, Bai L, Ye L, Zhong L, Duan X, Zhu Y. Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int J Biol Macromol. 2018;107:204\u201311. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.08.155.","journal-title":"Int J Biol Macromol"},{"key":"1520_CR90","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1471-4159.2008.05492.x","volume":"26","author":"S Pawar","year":"2021","unstructured":"Demeule M, Currie JC, Bertrand Y, Ch\u00e9 C, Nguyen T, R\u00e9gina A, Gabathuler R, Castaigne JP, B\u00e9liveau R: Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008; 106:1534-1544. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05492.x","journal-title":"Drug Discovery Today"},{"key":"1520_CR91","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.biomaterials.2014.10.007","volume":"37","author":"S Ruan","year":"2015","unstructured":"Ruan S, Yuan M, Zhang L, Hu G, Chen J, Cun X, Zhang Q, Yang Y, He Q, Gao H. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials. 2015;37:425\u201335. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.10.007.","journal-title":"Biomaterials"},{"key":"1520_CR92","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2021.02.138","volume":"551","author":"H Xu","year":"2021","unstructured":"Xu H, Li C, Wei Y, Zheng H, Zheng H, Wang B, Piao JG, Li F. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy. Biochem Biophys Res Commun. 2021;551:14\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1520_CR93","doi-asserted-by":"publisher","first-page":"215713","DOI":"10.1016\/j.canlet.2022.215713","volume":"539","author":"A Tyagi","year":"2022","unstructured":"Tyagi A, Wu SY, Watabe K. Metabolism in the progression and metastasis of brain tumors. Cancer Lett. 2022;539:215713. https:\/\/doi.org\/10.1016\/j.canlet.2022.215713.","journal-title":"Cancer Lett"},{"key":"1520_CR94","doi-asserted-by":"publisher","first-page":"16626","DOI":"10.1038\/s41598-024-67718-y","volume":"14","author":"M Kopec","year":"2024","unstructured":"Kopec M, Beton-Mysur K, Surmacki J, Abramczyk H. Metabolism changes caused by glucose in normal and cancer human brain cell lines by Raman imaging and chemometric methods. Sci Rep. 2024;14:16626. https:\/\/doi.org\/10.1038\/s41598-024-67718-y.","journal-title":"Sci Rep"},{"key":"1520_CR95","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41598-018-36340-0","volume":"10","author":"X Lin","year":"2020","unstructured":"Mainprize T, Lipsman N, Huang Y, et al. Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study. Sci Rep. 2019;9:321. https:\/\/doi.org\/10.1038\/s41598-018-36340-0","journal-title":"Front Oncol"},{"key":"1520_CR96","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1073\/pnas.2103280118","volume":"15","author":"S Wang","year":"2020","unstructured":"Anastasiadis P, Gandhi D, Guo Y, et al. Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound. Proc Natl Acad Sci U S A. 2021;118:e2103280118. https:\/\/doi.org\/10.1073\/pnas.2103280118","journal-title":"Int J Nanomed"},{"key":"1520_CR97","doi-asserted-by":"publisher","first-page":"107964","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther. 2022;230:107964. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107964.","journal-title":"Pharmacol Ther"},{"key":"1520_CR98","doi-asserted-by":"publisher","first-page":"115103","DOI":"10.1016\/j.bcp.2022.115103","volume":"201","author":"N Cappoli","year":"2022","unstructured":"Cappoli N, Jenkinson MD, Dello Russo C, Dickens D. LAT1, a novel pharmacological target for the treatment of glioblastoma. Biochem Pharmacol. 2022;201:115103. https:\/\/doi.org\/10.1016\/j.bcp.2022.115103.","journal-title":"Biochem Pharmacol"},{"key":"1520_CR99","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1007\/s12274-023-5568-3","volume":"16","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cheng Q, Xue Y, Yao K, Syeda MZ, Xu J, Wu J, Wang Z, Tang L, Mu Q. LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy. Nano Res. 2023;16:9743\u201351. https:\/\/doi.org\/10.1007\/s12274-023-5568-3.","journal-title":"Nano Res"},{"key":"1520_CR100","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jlcr.4023","volume":"66","author":"R Blades","year":"2023","unstructured":"Blades R, Ittner LM, Tietz O. Peptides for trans-blood-brain barrier delivery. J Label Comp Radiopharm. 2023;66:237\u201348. https:\/\/doi.org\/10.1002\/jlcr.4023.","journal-title":"J Label Comp Radiopharm"},{"key":"1520_CR101","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1517\/13543784.17.8.1225","volume":"17","author":"DA Reardon","year":"2008","unstructured":"Reardon DA, Nabors LB, Stupp R, Mikkelsen T. Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme. Expert Opin Investig Drugs. 2008;17:1225\u201335. https:\/\/doi.org\/10.1517\/13543784.17.8.1225.","journal-title":"Expert Opin Investig Drugs"},{"key":"1520_CR102","doi-asserted-by":"publisher","unstructured":"Ghorai SM, Deep A, Magoo D, Gupta C, Gupta N. Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB). Pharmaceutics. 2023;15. https:\/\/doi.org\/10.3390\/pharmaceutics15071999.","DOI":"10.3390\/pharmaceutics15071999"},{"key":"1520_CR103","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","volume":"10","author":"F Herve","year":"2008","unstructured":"Herve F, Ghinea N, Scherrmann JM. CNS delivery via adsorptive transcytosis. AAPS J. 2008;10:455\u201372. https:\/\/doi.org\/10.1208\/s12248-008-9055-2.","journal-title":"AAPS J"},{"key":"1520_CR104","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1039\/c6cs00076b","volume":"45","author":"B Oller-Salvia","year":"2016","unstructured":"Oller-Salvia B, Sanchez-Navarro M, Giralt E, Teixido M. Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chem Soc Rev. 2016;45:4690\u2013707. https:\/\/doi.org\/10.1039\/c6cs00076b.","journal-title":"Chem Soc Rev"},{"key":"1520_CR105","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.2147\/IJN.S255902","volume":"15","author":"MS Ashrafzadeh","year":"2020","unstructured":"Ashrafzadeh MS, Akbarzadeh A, Heydarinasab A, Ardjmand M. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin. Int J Nanomed. 2020;15:7035\u201349. https:\/\/doi.org\/10.2147\/IJN.S255902.","journal-title":"Int J Nanomed"},{"key":"1520_CR106","doi-asserted-by":"publisher","unstructured":"Dash BS, Lu YJ, Luo SH, Chen JP. Cetuximab-Conjugated Magnetic Poly(Lactic-co-Glycolic Acid) Nanoparticles for Dual-Targeted Delivery of Irinotecan in Glioma Treatment. Mater (Basel). 2023;16. https:\/\/doi.org\/10.3390\/ma16165526.","DOI":"10.3390\/ma16165526"},{"key":"1520_CR107","doi-asserted-by":"publisher","first-page":"eaay1344","DOI":"10.1126\/sciadv.aay1344","volume":"6","author":"CT Curley","year":"2020","unstructured":"Curley CT, Mead BP, Negron K, Kim N, Garrison WJ, Miller GW, Kingsmore KM, Thim EA, Song J, Munson JM, et al. Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection. Sci Adv. 2020;6:eaay1344. https:\/\/doi.org\/10.1126\/sciadv.aay1344.","journal-title":"Sci Adv"},{"key":"1520_CR108","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jconrel.2023.01.085","volume":"355","author":"D Das","year":"2023","unstructured":"Das D, Narayanan D, Ramachandran R, Gowd GS, Manohar M, Arumugam T, Panikar D, Nair SV, Koyakutty M. Intracranial nanomedicine-gel with deep brain-penetration for glioblastoma therapy. J Control Release. 2023;355:474\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.085.","journal-title":"J Control Release"},{"key":"1520_CR109","doi-asserted-by":"publisher","first-page":"eadi1617","DOI":"10.1126\/scitranslmed.adi1617","volume":"15","author":"M Khang","year":"2023","unstructured":"Khang M, Lee JH, Lee T, Suh HW, Lee S, Cavaliere A, Rushing A, Geraldo LH, Belitzky E, Rossano S, et al. Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma. Sci Transl Med. 2023;15:eadi1617. https:\/\/doi.org\/10.1126\/scitranslmed.adi1617.","journal-title":"Sci Transl Med"},{"key":"1520_CR110","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41551-021-00728-7","volume":"5","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jiang Y, Wei D, Singh P, Yu Y, Lee T, Zhang L, Mandl HK, Piotrowski-Daspit AS, Chen X, et al. Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance. Nat Biomed Eng. 2021;5:1048\u201358. https:\/\/doi.org\/10.1038\/s41551-021-00728-7.","journal-title":"Nat Biomed Eng"},{"key":"1520_CR111","doi-asserted-by":"publisher","first-page":"23838","DOI":"10.1039\/d0nr05053a","volume":"12","author":"G Brachi","year":"2020","unstructured":"Brachi G, Ruiz-Ramirez J, Dogra P, Wang Z, Cristini V, Ciardelli G, Rostomily RC, Ferrari M, Mikheev AM, Blanco E, Mattu C. Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma. Nanoscale. 2020;12:23838\u201350. https:\/\/doi.org\/10.1039\/d0nr05053a.","journal-title":"Nanoscale"},{"key":"1520_CR112","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/nop\/npab065","volume":"9","author":"JH Kang","year":"2022","unstructured":"Kang JH, Desjardins A. Convection-enhanced delivery for high-grade glioma. Neurooncol Pract. 2022;9:24\u201334. https:\/\/doi.org\/10.1093\/nop\/npab065.","journal-title":"Neurooncol Pract"},{"key":"1520_CR113","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11060-020-03408-9","volume":"151","author":"RS D\u2019Amico","year":"2021","unstructured":"D\u2019Amico RS, Aghi MK, Vogelbaum MA, Bruce JN. Convection-enhanced drug delivery for glioblastoma: a review. J Neurooncol. 2021;151:415\u201327. https:\/\/doi.org\/10.1007\/s11060-020-03408-9.","journal-title":"J Neurooncol"},{"key":"1520_CR114","doi-asserted-by":"publisher","first-page":"eabq7459","DOI":"10.1126\/sciadv.abq7459","volume":"9","author":"Y Wang","year":"2023","unstructured":"Wang Y, Malik S, Suh HW, Xiao Y, Deng Y, Fan R, Huttner A, Bindra RS, Singh V, Saltzman WM, Bahal R. Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Sci Adv. 2023;9:eabq7459. https:\/\/doi.org\/10.1126\/sciadv.abq7459.","journal-title":"Sci Adv"},{"key":"1520_CR115","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/IJN.S504629","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu Y, Si L, Jiang Y, Jiang S, Zhang X, Li S, Chen J, Hu J. Design of pH-Responsive Nanomaterials Based on the Tumor Microenvironment. Int J Nanomed. 2025;20:705\u201321. https:\/\/doi.org\/10.2147\/IJN.S504629.","journal-title":"Int J Nanomed"},{"key":"1520_CR116","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12:991\u20131003. https:\/\/doi.org\/10.1038\/nmat3776.","journal-title":"Nat Mater"},{"key":"1520_CR117","doi-asserted-by":"publisher","first-page":"14145","DOI":"10.1021\/acsnano.3c03409","volume":"18","author":"P Dosta","year":"2024","unstructured":"Dosta P, Dion MZ, Prado M, Hurtado P, Riojas-Javelly CJ, Cryer AM, Soria Y, Andrews Interiano N, Munoz-Taboada G, Artzi N. Matrix Metalloproteinase- and pH-Sensitive Nanoparticle System Enhances Drug Retention and Penetration in Glioblastoma. ACS Nano. 2024;18:14145\u201360. https:\/\/doi.org\/10.1021\/acsnano.3c03409.","journal-title":"ACS Nano"},{"key":"1520_CR118","doi-asserted-by":"publisher","unstructured":"Zhang S, Deng G, Liu F, Peng B, Bao Y, Du F, Chen AT, Liu J, Chen Z, Ma J, et al. Autocatalytic Delivery of Brain Tumor-targeting, Size-shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases. Adv Funct Mater. 2020;30. https:\/\/doi.org\/10.1002\/adfm.201910651.","DOI":"10.1002\/adfm.201910651"},{"key":"1520_CR119","doi-asserted-by":"publisher","unstructured":"Gaddimath S, Payamalle S, Channabasavana Hundi Puttaningaiah KP, Hur J. Recent Advances in pH and Redox Responsive Polymer Nanocomposites for Cancer Therapy. 2024;8:28. https:\/\/doi.org\/10.3390\/jcs8010028","DOI":"10.3390\/jcs8010028"},{"key":"1520_CR120","doi-asserted-by":"publisher","unstructured":"Rustad EAL, von Hofsten S, Kumar R, Laensman EA, Berge G, Skalko-Basnet N. The pH-Responsive Liposomes-The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14061125.","DOI":"10.3390\/pharmaceutics14061125"},{"key":"1520_CR121","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41467-024-44963-3","volume":"11","author":"L Lv","year":"2020","unstructured":"Zhang Z, Xu X, Du J, et al. Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy. Nat Commun. 2024;15:1118. https:\/\/doi.org\/10.1038\/s41467-024-44963-3","journal-title":"Front Pharmacol"},{"key":"1520_CR122","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1039\/d4ra01026d","volume":"14","author":"Q Guo","year":"2024","unstructured":"Guo Q, Wang S, Xu R, Tang Y, Xia X. Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform. RSC Adv. 2024;14:10608\u201337. https:\/\/doi.org\/10.1039\/d4ra01026d.","journal-title":"RSC Adv"},{"key":"1520_CR123","doi-asserted-by":"publisher","first-page":"160181","DOI":"10.1016\/j.cej.2025.160181","volume":"507","author":"J Lin","year":"2025","unstructured":"Lin J, Sun Z, Huang Y, Liu Q, Shen M, Shao C, Liao W, Yang Y, Song Y, Wang Y, et al. Glioma stem cell membrane-camouflaged photothermal nanozyme for synergistic antitumor via dual-targeted drug delivery across blood-brain barrier. Chem Eng J. 2025;507:160181. https:\/\/doi.org\/10.1016\/j.cej.2025.160181.","journal-title":"Chem Eng J"},{"key":"1520_CR124","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7555\/JBR.38.20240100","volume":"39","author":"C Tang","year":"2024","unstructured":"Tang C, Wang Y, Wu M, Wang Z, Zhou Y, Lin Y, Wang Y, Xu H. Cancer cell membrane-camouflaged biomimetic nanoparticles for enhancing chemo-radiation therapy efficacy in glioma. J Biomed Res. 2024;39:87\u2013102. https:\/\/doi.org\/10.7555\/JBR.38.20240100.","journal-title":"J Biomed Res"},{"key":"1520_CR125","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","volume":"22","author":"T Yin","year":"2022","unstructured":"Yin T, Fan Q, Hu F, Ma X, Yin Y, Wang B, Kuang L, Hu X, Xu B, Wang Y. Engineered Macrophage-Membrane-Coated Nanoparticles with Enhanced PD-1 Expression Induce Immunomodulation for a Synergistic and Targeted Antiglioblastoma Activity. Nano Lett. 2022;22:6606\u201314. https:\/\/doi.org\/10.1021\/acs.nanolett.2c01863.","journal-title":"Nano Lett"},{"key":"1520_CR126","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/15384047.2022.2088984","volume":"23","author":"A Hsu","year":"2022","unstructured":"Hsu A, Huntington KE, De Souza A, Zhou L, Olszewski AJ, Makwana NP, Treaba DO, Cavalcante L, Giles FJ, Safran H, et al. Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3beta) inhibitor, in refractory adult T-Cell leukemia\/lymphoma. Cancer Biol Ther. 2022;23:417\u201323. https:\/\/doi.org\/10.1080\/15384047.2022.2088984.","journal-title":"Cancer Biol Ther"},{"key":"1520_CR127","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1158\/1078-0432.CCR-19-2182","volume":"26","author":"DY Zhang","year":"2020","unstructured":"Zhang DY, Dmello C, Chen L, Arrieta VA, Gonzalez-Buendia E, Kane JR, Magnusson LP, Baran A, James CD, Horbinski C, et al. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clin Cancer Res. 2020;26:477\u201386. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2182.","journal-title":"Clin Cancer Res"},{"key":"1520_CR128","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.18632\/oncotarget.28018","volume":"12","author":"A Gould","year":"2021","unstructured":"Gould A, Zhang D, Arrieta VA, Stupp R, Sonabend AM. Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas. Oncotarget. 2021;12:2474\u20135. https:\/\/doi.org\/10.18632\/oncotarget.28018.","journal-title":"Oncotarget"},{"key":"1520_CR129","doi-asserted-by":"publisher","unstructured":"Aubrun C, Doussineau T, Carmes L, Meyzaud A, Boux F, Dufort S, Delfour A, De Beaumont O, Mirjolet C, Le Duc G. Mechanisms of Action of AGuIX as a Pan-Cancer Nano-Radiosensitizer: A Comprehensive Review. Pharmaceuticals (Basel). 2025;18. https:\/\/doi.org\/10.3390\/ph18040519.","DOI":"10.3390\/ph18040519"},{"key":"1520_CR130","doi-asserted-by":"publisher","first-page":"12299","DOI":"10.1002\/anie.201104104","volume":"50","author":"F Lux","year":"2011","unstructured":"Lux F, Mignot A, Mowat P, Louis C, Dufort S, Bernhard C, Denat F, Boschetti F, Brunet C, Antoine R, et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl. 2011;50:12299\u2013303. https:\/\/doi.org\/10.1002\/anie.201104104.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1520_CR131","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.radonc.2021.04.021","volume":"160","author":"C Verry","year":"2021","unstructured":"Verry C, Dufort S, Villa J, Gavard M, Iriart C, Grand S, Charles J, Chovelon B, Cracowski JL, Quesada JL, et al. Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial). Radiother Oncol. 2021;160:159\u201365. https:\/\/doi.org\/10.1016\/j.radonc.2021.04.021.","journal-title":"Radiother Oncol"},{"key":"1520_CR132","doi-asserted-by":"publisher","first-page":"e023591","DOI":"10.1136\/bmjopen-2018-023591","volume":"9","author":"C Verry","year":"2019","unstructured":"Verry C, Sancey L, Dufort S, Le Duc G, Mendoza C, Lux F, Grand S, Arnaud J, Quesada JL, Villa J, et al. Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol. BMJ Open. 2019;9:e023591. https:\/\/doi.org\/10.1136\/bmjopen-2018-023591.","journal-title":"BMJ Open"},{"key":"1520_CR133","doi-asserted-by":"publisher","first-page":"11959","DOI":"10.1038\/s41598-024-62389-1","volume":"14","author":"S Bennett","year":"2024","unstructured":"Bennett S, Verry C, Kaza E, Miao X, Dufort S, Boux F, Cremillieux Y, de Beaumont O, Le Duc G, Berbeco R, Sudhyadhom A. Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging. Sci Rep. 2024;14:11959. https:\/\/doi.org\/10.1038\/s41598-024-62389-1.","journal-title":"Sci Rep"},{"key":"1520_CR134","doi-asserted-by":"publisher","first-page":"100833","DOI":"10.1016\/j.ctro.2024.100833","volume":"48","author":"J Biau","year":"2024","unstructured":"Biau J, Durando X, Boux F, Molnar I, Moreau J, Leyrat B, Guillemin F, Lavielle A, Cremillieux Y, Seddik K, et al. NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution. Clin Transl Radiat Oncol. 2024;48:100833. https:\/\/doi.org\/10.1016\/j.ctro.2024.100833.","journal-title":"Clin Transl Radiat Oncol"},{"key":"1520_CR135","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12885-023-10829-y","volume":"23","author":"E Thivat","year":"2023","unstructured":"Thivat E, Casile M, Moreau J, Molnar I, Dufort S, Seddik K, Le Duc G, De Beaumont O, Loeffler M, Durando X, Biau J. Phase I\/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol). BMC Cancer. 2023;23:344. https:\/\/doi.org\/10.1186\/s12885-023-10829-y.","journal-title":"BMC Cancer"},{"key":"1520_CR136","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","volume":"15","author":"Y Xu","year":"2024","unstructured":"Xu Y, Ma S, Cui H, Chen J, Xu S, Gong F, Golubovic A, Zhou M, Wang KC, Varley A, et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat Commun. 2024;15:6305. https:\/\/doi.org\/10.1038\/s41467-024-50619-z.","journal-title":"Nat Commun"},{"key":"1520_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02490-y","author":"J Witten","year":"2024","unstructured":"Witten J, Raji I, Manan RS, Beyer E, Bartlett S, Tang Y, Ebadi M, Lei J, Nguyen D, Oladimeji F, et al. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat Biotechnol. 2024. https:\/\/doi.org\/10.1038\/s41587-024-02490-y.","journal-title":"Nat Biotechnol"},{"key":"1520_CR138","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41467-025-55987-8","volume":"16","author":"J Yang","year":"2025","unstructured":"Yang J, Lal RG, Bowden JC, Astudillo R, Hameedi MA, Kaur S, Hill M, Yue Y, Arnold FH. Active learning-assisted directed evolution. Nat Commun. 2025;16:714. https:\/\/doi.org\/10.1038\/s41467-025-55987-8.","journal-title":"Nat Commun"},{"key":"1520_CR139","doi-asserted-by":"publisher","first-page":"109383","DOI":"10.1016\/j.cclet.2023.109383","volume":"35","author":"C Wang","year":"2024","unstructured":"Wang C, Huang L, Wang S, Wu L, Wang Y, Dong J. A distinction of gliomas at cellular and tissue level by surface-enhanced Raman scattering spectroscopy. Chin Chem Lett. 2024;35:109383. https:\/\/doi.org\/10.1016\/j.cclet.2023.109383.","journal-title":"Chin Chem Lett"},{"key":"1520_CR140","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jconrel.2024.08.015","volume":"374","author":"K Mi","year":"2024","unstructured":"Mi K, Chou WC, Chen Q, Yuan L, Kamineni VN, Kuchimanchi Y, He C, Monteiro-Riviere NA, Riviere JE, Lin Z. Predicting tissue distribution and tumor delivery of nanoparticles in mice using machine learning models. J Control Release. 2024;374:219\u201329. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.015.","journal-title":"J Control Release"},{"key":"1520_CR141","doi-asserted-by":"publisher","first-page":"109392","DOI":"10.1016\/j.compbiomed.2024.109392","volume":"184","author":"N Ahmadi Daryakenari","year":"2025","unstructured":"Ahmadi Daryakenari N, Wang S, Karniadakis G. CMINNs: Compartment model informed neural networks - Unlocking drug dynamics. Comput Biol Med. 2025;184:109392. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109392.","journal-title":"Comput Biol Med"},{"key":"1520_CR142","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","volume":"361","author":"WC Chou","year":"2023","unstructured":"Chou WC, Chen Q, Yuan L, Cheng YH, He C, Monteiro-Riviere NA, Riviere JE, Lin Z. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice. J Control Release. 2023;361:53\u201363. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.040.","journal-title":"J Control Release"},{"key":"1520_CR143","doi-asserted-by":"publisher","unstructured":"Eyraud R, Ayache S, Tsvetkov PO, Kalidindi SS, Baksheeva VE, Boissonneau S, Jiguet-Jiglaire C, Appay R, Nanni-Metellus I, Chinot O, et al. Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15030760.","DOI":"10.3390\/cancers15030760"},{"key":"1520_CR144","doi-asserted-by":"publisher","unstructured":"Qiu Z, Yu Z, Xu T, Wang L, Meng N, Jin H, Xu B. Novel Nano-Drug Delivery System for Brain Tumor Treatment. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11233761.","DOI":"10.3390\/cells11233761"},{"key":"1520_CR145","doi-asserted-by":"publisher","unstructured":"Ahmad F, Varghese R, Panda S, Ramamoorthy S, Areeshi MY, Fagoonee S, Haque S. Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14215389.","DOI":"10.3390\/cancers14215389"},{"key":"1520_CR146","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.onano.2023.100128","volume":"10","author":"V Kurawattimath","year":"2023","unstructured":"Kurawattimath V, Wilson B, Geetha KM. Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma. OpenNano. 2023;10:100128. https:\/\/doi.org\/10.1016\/j.onano.2023.100128.","journal-title":"OpenNano"},{"key":"1520_CR147","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12935-024-03331-3","volume":"24","author":"H Ghaznavi","year":"2024","unstructured":"Ghaznavi H, Afzalipour R, Khoei S, Sargazi S, Shirvalilou S, Sheervalilou R. New insights into targeted therapy of glioblastoma using smart nanoparticles. Cancer Cell Int. 2024;24:160. https:\/\/doi.org\/10.1186\/s12935-024-03331-3.","journal-title":"Cancer Cell Int"},{"key":"1520_CR148","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12951-025-03572-y","volume":"23","author":"S Yuan","year":"2025","unstructured":"Yuan S, Hu D, Gao D, Butch CJ, Wang Y, Zheng H, Sheng Z. Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier. J Nanobiotechnol. 2025;23:493. https:\/\/doi.org\/10.1186\/s12951-025-03572-y.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR149","doi-asserted-by":"publisher","unstructured":"Fornaguera C, Garcia-Celma MJ. Personalized Nanomedicine: A Revolution at the Nanoscale. J Pers Med. 2017;7. https:\/\/doi.org\/10.3390\/jpm7040012.","DOI":"10.3390\/jpm7040012"},{"key":"1520_CR150","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12951-024-02835-4","volume":"22","author":"H Mengyuan","year":"2024","unstructured":"Mengyuan H, Aixue L, Yongwei G, Qingqing C, Huanhuan C, Xiaoyan L, Jiyong L. Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication. J Nanobiotechnol. 2024;22:604. https:\/\/doi.org\/10.1186\/s12951-024-02835-4.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR151","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12967-021-02766-w","volume":"19","author":"J Yao","year":"2021","unstructured":"Yao J, Wang Z, Cheng Y, Ma C, Zhong Y, Xiao Y, Gao X, Li Z. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K\/AKT\/mTOR signaling pathway. J Transl Med. 2021;19:99. https:\/\/doi.org\/10.1186\/s12967-021-02766-w.","journal-title":"J Transl Med"},{"key":"1520_CR152","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16:71. https:\/\/doi.org\/10.1186\/s12951-018-0392-8.","journal-title":"J Nanobiotechnol"},{"key":"1520_CR153","doi-asserted-by":"publisher","first-page":"e2311760","DOI":"10.1002\/adma.202311760","volume":"36","author":"M Song","year":"2024","unstructured":"Song M, Tian J, Wang L, Dong S, Fu K, Chen S, Liu C. Efficient Delivery of Lomitapide using Hybrid Membrane-Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy. Adv Mater. 2024;36:e2311760. https:\/\/doi.org\/10.1002\/adma.202311760.","journal-title":"Adv Mater"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01520-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:30:55Z","timestamp":1789716655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-026-01520-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01520-3","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethics approval was necessary as this work is a literature review.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No informed consent was required as this review did not involve participants or original data collection","order":3,"name":"Ethics","label":"Consent to participate\/Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}